Results 241 to 250 of about 68,171 (350)

Addiction‐related problems in Japan: A regional perspective

Addiction, EarlyView.
Abstract Japan's addiction landscape appears paradoxical. The lifetime use of illicit drugs is among the lowest in Organisation for Economic Cooperation and Development countries, but harm from alcohol, tobacco, and gambling ranks among the world's highest.
Soichiro Ide, Yoko Nishitani, Masahiko Sumitani, Masabumi Minami, Tadashi Isa, Masako Iseki, Michiko Ohkura, Hitoshi Okamoto, Tetsuro Kikuchi, Yuko Sekino, Hidehiko Takahashi, Kenji Takeuchi, Atsumi Nitta, Takeshi Honjo, Hiroshi Matsumoto, Tsuyoshi Miyakawa, Toshiya Murai, Toshihiko Matsumoto, Kazuyuki Nakagome, Kazutaka Ikeda   +19 more
wiley   +1 more source

Healthcare Expenditures Associated With Implementing an External Facilitation Program to Increase the Prescribing of Medications Used for the Treatment of Opioid Use Disorder Among Veterans

A Esmaeili, Hildi Hagedorn, Carla Costa Garcia, Ann Bangerter, Allison M. Gustavson, Marie E. Kenny, W Miller, Princess E. Ackland, Barbara Clothier, Siamak Noorbaloochi, Adam J. Gordon, Mark Bounthavong   +11 more
openalex   +2 more sources

Racial Differences in Medications for Opioid Use Disorder Initiation in a Carceral Setting [PDF]

Justin Berk, Jessica Brar, Ariel Hoadley, Rosemarie A. Martin   +3 more
openalex   +1 more source

Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada

Addiction, EarlyView.
Abstract Background and aims Canada's drug toxicity crisis has been largely attributed to a volatile fentanyl‐dominated unregulated drug supply with increasing reports of fentanyl detected in combination with benzodiazepines, stimulants and xylazine.
Shaleesa Ledlie, Ria Garg, Pamela Leece, Gillian Kolla, Elaine Hyshka, Mina Tadrous, Tara Gomes   +6 more
wiley   +1 more source

Evaluating a mobile app's effects on depression and anxiety in medication-treated opioid use disorder. [PDF]

Npj Ment Health Res
Heinz MV, Lekkas D, Abreu V, Lee C, Marsch LA, Jacobson NC.   +5 more
europepmc   +1 more source

Influences of the criminal justice system on use of medications for opioid use disorder: a qualitative study [PDF]

Emmeline Taylor, Caroline Gray, Matthew Stimmel, Ingrid A. Binswanger, Erica Morse, Christine Timko, Alex H. S. Harris, David Smelson, Andrea K. Finlay   +8 more
openalex   +1 more source

Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA

Addiction, EarlyView.
Abstract Background and aims The state of Kentucky has been heavily impacted by the ongoing opioid crisis in the United States, with high overdose mortality, high prevalence of opioid use disorder (OUD), elevated maternal mortality and incidence of Neonatal Abstinence Syndrome.
Hilary L. Surratt, Olivia A. Davis, Elizabeth O. Nelson, Hayley Durr, Karen Fawcett, Jason Joy, Brandon L. Schanbacher, Marie Vice, John A. Bauer, Wendy F. Hansen   +9 more
wiley   +1 more source

Impact of implementing primary care-based medication for opioid use disorder on provider and staff perceptions. [PDF]

Fam Pract
Mazzarelli S, Blewer AL, Østbye T, Rhodes K, Plasencia G, Hart L, Sawin G.   +6 more
europepmc   +1 more source

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, EarlyView.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults [PDF]

Kaitlyn Jaffe, Stephanie Slat, Liying Chen, Colin Macleod, Amy Bohnert, Pooja Lagisetty   +5 more
openalex   +1 more source